Open AccessDifferent presentation of pulmonary parenchymal disruption in COVID-19 pneumonia. Case series of Sub-Intensive Care Unit in Naples, Italy
Author(s) -
Giorgio Emanuele Polistina,
Francesca Simioli,
Pasquale Imitazione,
Maurizia Lanza,
Anna Annunziata,
Giuseppe Fiorentino
Publication year - 2020
Publication title -
monaldi archives for chest disease. pulmonary series/monaldi archives for chest disease/monaldi archives for chest disease. cardiac series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.196
H-Index - 46
eISSN - 2465-101X
pISSN - 1122-0643
DOI - 10.4081/monaldi.2020.1482
Subject(s) - pneumomediastinum , medicine , pneumothorax , bronchiectasis , covid-19 , pneumonia , pandemic , intensive care unit , intensive care medicine , radiology , presentation (obstetrics) , disease , halo sign , computed tomography , pediatrics , lung , infectious disease (medical specialty)
The coronavirus disease 2019 (COVID-19) is a recent pandemic that affected more than 5 million people worldwide. Chest high resolution computed tomography (HRCT) is an essential tool in diagnosis and management of the disease. Pulmonary parenchymal opacity is a typical sign of the disease, but not the only one. Pneumothorax, pneumomediastinum, bronchiectasis and cysts are probably underrated complications of COVID-19 that can worsen prognosis, in terms of prolonged hospitalization and need of oxygen therapy. In our single center case series, we outline four different manifestations of pneumothorax, pneumomediastinum and cysts in hospitalized patients with COVID-19 pneumonia.